Your search returned 92 studies:
- Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission
Conditions: Leukemia
Location: Hartford, Connecticut
- Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission
Conditions: Leukemia
Location: New Haven, Connecticut
- Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
Conditions: Cognitive/Functional Effects - Leukemia - Long-term Effects Secondary to Cancer Therapy in Children - Neurotoxicity - Psychosocial Effects of Cancer and Its Treatment
Location: Hartford, Connecticut
- Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
Conditions: Cognitive/Functional Effects - Leukemia - Long-term Effects Secondary to Cancer Therapy in Children - Neurotoxicity - Psychosocial Effects of Cancer and Its Treatment
Location: New Haven, Connecticut
- Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Long-term Effects Secondary to Cancer Therapy in Children - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic S
Location: Hartford, Connecticut
- Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Long-term Effects Secondary to Cancer Therapy in Children - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic S
Location: New Haven, Connecticut
- Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD
Conditions: Graft Versus Host Disease - Leukemia - Myelodysplastic Syndromes
Location: New Haven, Connecticut
- Study of Blood Samples From Newborns With Down Syndrome
Conditions: Leukemia
Location: Hartford, Connecticut
- Study of Blood Samples From Newborns With Down Syndrome
Conditions: Leukemia
Location: New Haven, Connecticut
- Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute M
Conditions: Leukemia
Location: New Britain, Connecticut
- Levofloxacin in Preventing Infection in Young Patients Receiving Chemotherapy For Acute Leukemia or Undergoing Stem Cell Transplantation
Conditions: Bacterial Infection - Leukemia - Musculoskeletal Complications - Neutropenia
Location: Hartford, Connecticut
- Pentostatin, Cyclophosphamide, and Rituximab Followed By Lenalidomide in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leuk
Conditions: Leukemia
Location: Hartford, Connecticut
- Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission
Conditions: Leukemia
Location: Stony Brook, New York
- Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission
Conditions: Leukemia
Location: Valhalla, New York
- Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Hartford, Connecticut
- Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: New Haven, Connecticut
- Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant
Conditions: Graft Versus Host Disease - Leukemia
Location: Valhalla, New York
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: Contiguous Stage II Adult Lymphoblastic Lymphoma - Noncontiguous Stage II Adult Lymphoblastic Lymphoma - Stage II Adult T-cell Leukemia/Lymphoma - Stage II Childhood Lymphoblastic Lymphoma - Stage III Adult Lymphoblastic Lymphoma - Stage III Adult T-cell
Location: Hartford, Connecticut
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: Contiguous Stage II Adult Lymphoblastic Lymphoma - Noncontiguous Stage II Adult Lymphoblastic Lymphoma - Stage II Adult T-cell Leukemia/Lymphoma - Stage II Childhood Lymphoblastic Lymphoma - Stage III Adult Lymphoblastic Lymphoma - Stage III Adult T-cell
Location: New Haven, Connecticut
- S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Hartford, Connecticut
- Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Hartford, Connecticut
- Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Valhalla, New York
- Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
Conditions: Acute Myeloid Leukemia
Location: Hawthorne, New York
- Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Long-term Effects Secondary to Cancer Therapy in Children - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic S
Location: Valhalla, New York
- A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Followi
Conditions: B-cell Chronic Lymphocytic Leukemia
Location: Southington, Connecticut
- Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoma
Location: Hartford, Connecticut
- Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoma
Location: New Haven, Connecticut
- Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoma
Location: Stony Brook, New York
- Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoma
Location: Valhalla, New York
- Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Conditions: Leukemia - Lymphoma
Location: Hartford, Connecticut
- Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Conditions: Leukemia - Lymphoma
Location: Stony Brook, New York
- Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Conditions: Leukemia - Lymphoma
Location: Valhalla, New York
- Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
Conditions: Leukemia - Lymphoma
Location: Hartford, Connecticut
- Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
Conditions: Leukemia - Neoplasm of Uncertain Malignant Potential - Unspecified Childhood Solid Tumor, Protocol Specific
Location: Hartford, Connecticut
- Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
Conditions: Leukemia - Neoplasm of Uncertain Malignant Potential - Unspecified Childhood Solid Tumor, Protocol Specific
Location: Stony Brook, New York
- Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
Conditions: Leukemia - Neoplasm of Uncertain Malignant Potential - Unspecified Childhood Solid Tumor, Protocol Specific
Location: Valhalla, New York
- Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes
Conditions: Leukemia - Lymphoma - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
Location: Hartford, Connecticut
- Study of Blood Samples From Newborns With Down Syndrome
Conditions: Leukemia
Location: Stony Brook, New York
- CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant
Conditions: Leukemia - Lymphoma - Bone Marrow Failure - Immunodeficiencies - Histiocytosis
Location: Valhalla, New York
- Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Conditions: Chronic Lymphocytic Leukemia
Location: Bay Shore, New York
- Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Hartford, Connecticut
- Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: New Haven, Connecticut
- Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Stony Brook, New York
- Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Valhalla, New York
- MLN8237 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia
Conditions: Brain and Central Nervous System Tumors - Childhood Germ Cell Tumor - Kidney Cancer - Leukemia - Liver Cancer - Neuroblastoma - Sarcoma
Location: Valhalla, New York
- MLN8237 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia
Conditions: Brain and Central Nervous System Tumors - Childhood Germ Cell Tumor - Kidney Cancer - Leukemia - Liver Cancer - Neuroblastoma - Sarcoma
Location: Hartford, Connecticut
- Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Stony Brook, New York
- Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Valhalla, New York
- Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Hartford, Connecticut
- Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: New Haven, Connecticut
- Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Conditions: Leukemia - Acute Myeloid Leukemia - Acute Nonlymphocytic Leukemia
Location: Stony Brook, New York
- Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Conditions: Leukemia - Acute Myeloid Leukemia - Acute Nonlymphocytic Leukemia
Location: Valhalla, New York
- Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Conditions: Myelodysplastic Syndromes - MDS - RAEB - Chronic Myelomonocytic Leukemia
Location: New Haven, Connecticut
- Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Conditions: Chronic Myeloid Leukemia
Location: Stony Brook, New York
- Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Conditions: Chronic Myeloid Leukemia
Location: Manchester, Connecticut
- A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Conditions: Acute Myeloid Leukemia
Location: Hawthorne, New York
- A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Conditions: Acute Myeloid Leukemia
Location: Stony Brook, New York
- A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Conditions: Acute Myeloid Leukemia
Location: Norwalk, Connecticut
- A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Conditions: Acute Myeloid Leukemia
Location: Southington, Connecticut
- Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
Conditions: Fungal Infection - Leukemia - Neutropenia
Location: Hartford, Connecticut
- Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
Conditions: Fungal Infection - Leukemia - Neutropenia
Location: New Haven, Connecticut
- Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
Conditions: Fungal Infection - Leukemia - Neutropenia
Location: Stony Brook, New York
- Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
Conditions: Fungal Infection - Leukemia - Neutropenia
Location: Valhalla, New York
- Bortezomib and Sorafenib Tosylate in Patients With Newly Diagnosed Acute Myeloid Leukemia With or Without Mutations
Conditions: Adult Acute Erythroid Leukemia (M6) - Adult Acute Megakaryoblastic Leukemia (M7) - Adult Acute Minimally Differentiated Myeloid Leukemia (M0) - Adult Acute Monoblastic Leukemia (M5a) - Adult Acute Monocytic Leukemia (M5b) - Adult Acute Myeloblastic Leukem
Location: Hartford, Connecticut
- Bortezomib and Sorafenib Tosylate in Patients With Newly Diagnosed Acute Myeloid Leukemia With or Without Mutations
Conditions: Adult Acute Erythroid Leukemia (M6) - Adult Acute Megakaryoblastic Leukemia (M7) - Adult Acute Minimally Differentiated Myeloid Leukemia (M0) - Adult Acute Monoblastic Leukemia (M5a) - Adult Acute Monocytic Leukemia (M5b) - Adult Acute Myeloblastic Leukem
Location: New Haven, Connecticut
- Bortezomib and Sorafenib Tosylate in Patients With Newly Diagnosed Acute Myeloid Leukemia With or Without Mutations
Conditions: Adult Acute Erythroid Leukemia (M6) - Adult Acute Megakaryoblastic Leukemia (M7) - Adult Acute Minimally Differentiated Myeloid Leukemia (M0) - Adult Acute Monoblastic Leukemia (M5a) - Adult Acute Monocytic Leukemia (M5b) - Adult Acute Myeloblastic Leukem
Location: Valhalla, New York
- Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Leukemias and Related Disorders
Conditions: Cancer - Hematologic Malignancies - Leukemia - Myeloid Leukemia
Location: Stony Brook, New York
- A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Conditions: Lymphoma
Location: Valhalla, New York
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Conditions: Cognitive/Functional Effects - Leukemia - Neurotoxicity - Pain - Therapy-related Toxicity
Location: Stony Brook, New York
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Conditions: Cognitive/Functional Effects - Leukemia - Neurotoxicity - Pain - Therapy-related Toxicity
Location: Valhalla, New York
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Conditions: Cognitive/Functional Effects - Leukemia - Neurotoxicity - Pain - Therapy-related Toxicity
Location: Hartford, Connecticut
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Conditions: Cognitive/Functional Effects - Leukemia - Neurotoxicity - Pain - Therapy-related Toxicity
Location: New Haven, Connecticut
- Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Conditions: Leukemia, Pediatric
Location: Hartford, Connecticut
- Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Conditions: Leukemia, Pediatric
Location: Valhalla, New York
- Maintenance Therapy: Lenalidomide Following Bendamustine and Rituximab Induction Therapy for Chronic Lymphocytic Leukemia
Conditions: Chronic Lymphocytic Leukemia
Location: New Haven, Connecticut
- Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Hepatosplenic T-cell Lymphoma - Peripheral T-cell Lymphoma - Recurrent Adult Non-Hodgkin Lymphoma - Recurrent Adult T-cell Leukemia/Lymp
Location: Hartford, Connecticut
- Study Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission
Conditions: Leukemia
Location: Hartford, Connecticut
- Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic Leukemia
Conditions: Acute Lymphoblastic Leukemia - Lymphoblastic Lymphoma - Burkitts Leukemia/Lymphoma - Chronic Myelogenous Leukemia
Location: Valhalla, New York
- Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Conditions: Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Refractory Anemia With Excess Blasts - Secondary Myelodysplastic Syndromes
Location: Hartford, Connecticut
- Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Conditions: Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Refractory Anemia With Excess Blasts - Secondary Myelodysplastic Syndromes
Location: New Britain, Connecticut
- A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Conditions: Relapsed or Refractory Chronic Lymphocytic Leukemia - Small Lymphocytic Lymphoma
Location: Norwalk, Connecticut
- Safety Study of Anti-Programmed Death-1 in Hematologic Malignancy
Conditions: Non-Hodgkin's Lymphoma - Hodgkin Lymphoma - Multiple Myeloma - Chronic Myelogenous Leukemia
Location: New Haven, Connecticut
- Combination Chemotherapy With or Without Rituximab in Treating Younger Patients With Stage III-IV Non-Hodgkin Lymphoma or B-Cell Acute Leukemia
Conditions: Leukemia - Lymphoma
Location: Hartford, Connecticut
- Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Conditions: Chronic Myeloid Leukemia
Location: Southington, Connecticut
- This Study Will be a Phase IV, Open-label, Multicenter Study of Dasatinib in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients With Chronic, Lo
Conditions: Chronic Phase Chronic Myeloid Leukemia
Location: Southington, Connecticut
- Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma
Conditions: Leukemia - Lymphoma
Location: Commack, New York
- Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Valhalla, New York
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: Contiguous Stage II Adult Lymphoblastic Lymphoma - Noncontiguous Stage II Adult Lymphoblastic Lymphoma - Stage II Adult T-cell Leukemia/Lymphoma - Stage II Childhood Lymphoblastic Lymphoma - Stage III Adult Lymphoblastic Lymphoma - Stage III Adult T-cell
Location: Valhalla, New York
- MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
Conditions: Acute Myeloid Leukemia
Location: Valhalla, New York
- Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Conditions: Chronic Myeloid Leukemia
Location: Valhalla, New York
- Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia
Conditions: High Risk Acute Myeloid Leukemia
Location: Valhalla, New York
- Mitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute Leukemia
Conditions: Acute Lymphoblastic Leukemia - Acute Myelogenous Leukemia - Lymphoblastic Lymphoma - Diffuse Large B-cell Lymphoma - Burkitt Lymphoma/Leukemia
Location: Vallhala, New York
|